1-2 of 2
Shom Goel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer

Lestat R. Ali, Ana C. Garrido-Castro, Patrick J. Lenehan, Naima Bollenrucher, Courtney T. Stump, Michael Dougan, Shom Goel, Geoffrey I. Shapiro, Sara M. Tolaney, Stephanie K. Dougan
Journal: Journal of Experimental Medicine
J Exp Med (2023) 220 (9): e2022072908182023c.
https://doi.org/10.1084/jem.2022072908182023c
Published: 24 August 2023
View article titled, Correction: PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
Open the PDF for Correction: PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer in another window
Journal Articles

PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer

In Special Collection:
JEM Cancer Collection 2023 , Cancer Immunotherapy Update 2024
Lestat R. Ali, Ana C. Garrido-Castro, Patrick J. Lenehan, Naima Bollenrucher, Courtney T. Stump, Michael Dougan, Shom Goel, Geoffrey I. Shapiro, Sara M. Tolaney, Stephanie K. Dougan
Journal: Journal of Experimental Medicine
J Exp Med (2023) 220 (4): e20220729.
https://doi.org/10.1084/jem.20220729
Published: 23 January 2023
View article titled, PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
Open the PDF for PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer in another window